These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36367726)

  • 1. Exploration of Residual Confounding in Analyses of Associations of Metformin Use and Outcomes in Adults With Type 2 Diabetes.
    Powell M; Clark C; Alyakin A; Vogelstein JT; Hart B
    JAMA Netw Open; 2022 Nov; 5(11):e2241505. PubMed ID: 36367726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a Health Plan Program for Switching From Analogue to Human Insulin and Glycemic Control Among Medicare Beneficiaries With Type 2 Diabetes.
    Luo J; Khan NF; Manetti T; Rose J; Kaloghlian A; Gadhe B; Jain SH; Gagne JJ; Kesselheim AS
    JAMA; 2019 Jan; 321(4):374-384. PubMed ID: 30694321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Cessation and Dementia Incidence.
    Zimmerman SC; Ferguson EL; Choudhary V; Ranatunga DK; Oni-Orisan A; Hayes-Larson E; Duarte Folle A; Mayeda ER; Whitmer RA; Gilsanz P; Power MC; Schaefer C; Glymour MM; Ackley SF
    JAMA Netw Open; 2023 Oct; 6(10):e2339723. PubMed ID: 37878309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sociodemographic, Clinical, and Treatment-Related Factors Associated With Hyperglycemic Crises Among Adults With Type 1 or Type 2 Diabetes in the US From 2014 to 2020.
    McCoy RG; Galindo RJ; Swarna KS; Van Houten HK; O'Connor PJ; Umpierrez GE; Shah ND
    JAMA Netw Open; 2021 Sep; 4(9):e2123471. PubMed ID: 34468753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019.
    McCoy RG; Van Houten HK; Deng Y; Mandic PK; Ross JS; Montori VM; Shah ND
    JAMA Netw Open; 2021 Feb; 4(2):e2035792. PubMed ID: 33523188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative.
    Vashisht R; Jung K; Schuler A; Banda JM; Park RW; Jin S; Li L; Dudley JT; Johnson KW; Shervey MM; Xu H; Wu Y; Natrajan K; Hripcsak G; Jin P; Van Zandt M; Reckard A; Reich CG; Weaver J; Schuemie MJ; Ryan PB; Callahan A; Shah NH
    JAMA Netw Open; 2018 Aug; 1(4):e181755. PubMed ID: 30646124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Preoperative Metformin Exposure and Postoperative Outcomes in Adults With Type 2 Diabetes.
    Reitz KM; Marroquin OC; Zenati MS; Kennedy J; Korytkowski M; Tzeng E; Koscum S; Newhouse D; Garcia RM; Vates J; Billiar TR; Zuckerbraun BS; Simmons RL; Shapiro S; Seymour CW; Angus DC; Rosengart MR; Neal MD
    JAMA Surg; 2020 Jun; 155(6):e200416. PubMed ID: 32267474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Spending Differences Between Beneficiaries in Medicare Advantage and the Medicare Shared Savings Program.
    Parikh RB; Emanuel EJ; Brensinger CM; Boyle CW; Price-Haywood EG; Burton JH; Heltz SB; Navathe AS
    JAMA Netw Open; 2022 Aug; 5(8):e2228529. PubMed ID: 35997977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus.
    Shi Q; Liu S; Fonseca VA; Thethi TK; Shi L
    BMJ Open; 2019 Jul; 9(7):e024954. PubMed ID: 31366635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihyperglycemic Medications: A Claims-Based Estimate of First-line Therapy Use Prior to Initialization of Second-line Medications.
    Tseng YJ; Steinberg G; Fox KP; Armstrong J; Mandl KD
    Diabetes Care; 2017 Nov; 40(11):1500-1505. PubMed ID: 28903978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiating second-line antidiabetic medication among older adults with type 2 diabetes on Metformin.
    DeCarlo K; Wallia A; Kang RH; Cooper A; Cherupally M; Harris SA; Aikman C; Liss DT; Ackermann RT; O'Brien MJ
    BMC Geriatr; 2022 Feb; 22(1):97. PubMed ID: 35114955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term metformin use and risk of pneumonia and related death in type 2 diabetes: a registry-based cohort study.
    Yang A; Shi M; Wu H; Lau ESH; Ma RCW; Kong APS; So WY; Luk AOY; Chan JCN; Chow E
    Diabetologia; 2021 Aug; 64(8):1760-1765. PubMed ID: 33844069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects on cardiovascular events between use of metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycaemic agents in Japanese patients with type 2 diabetes mellitus: a claims database analysis.
    Nishimura R; Takeshima T; Iwasaki K; Aoi S
    BMJ Open; 2022 Mar; 12(3):e045966. PubMed ID: 35277396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
    Simons WR; Hagan MA
    Pharmacoeconomics; 2010; 28(9):765-80. PubMed ID: 20799756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes.
    Chang HY; Singh S; Mansour O; Baksh S; Alexander GC
    JAMA Intern Med; 2018 Sep; 178(9):1190-1198. PubMed ID: 30105373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.
    Bowker SL; Majumdar SR; Veugelers P; Johnson JA
    Diabetes Care; 2006 Feb; 29(2):254-8. PubMed ID: 16443869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
    Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
    Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage.
    McWilliams JM; Zaslavsky AM; Huskamp HA
    JAMA; 2011 Jul; 306(4):402-9. PubMed ID: 21791689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes.
    Currie CJ; Poole CD; Evans M; Peters JR; Morgan CL
    J Clin Endocrinol Metab; 2013 Feb; 98(2):668-77. PubMed ID: 23372169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.